EUVIMEDEUVIMED entdecken
Crossref

Contrast-enhanced ultrasound reveals perfusion differences between benign lipoma and semi-malignant atypical lipomatous tumors: A prospective clinical study

Paul Mick, Antonia Seeberger, Tobias Renkawitz, Burkhard Lehner, Mustafa Hariri, Christian Fischer, Julian Doll

Ultraschall in der Medizin - European Journal of Ultrasound · 01.10.2024 · 45 (05) · 509-518

DOI: 10.1055/a-2189-5412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ultraschall in der Medizin - European Journal of Ultrasound, erschienen am 01.10.2024. Verfasst von Paul Mick und 6 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedics, University Hospital Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Contrast Media, Image Enhancement, Lipoma, Liposarcoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Soft tissue tumors (STT) are difficult to diagnose accurately, and distinguishing between benign and malignant tumors is challenging. Lipoma is the most common STT, while atypical lipomatous tumors (ALT) can dedifferentiate into malignant lipomatous tumors like grade 1 liposarcoma and require more radical therapy. This study aims to investigate the potential of contrast-enhanced ultrasound (CEUS) to differentiate between lipoma and ALT based on tumor perfusion. Materials and Methods We prospectively examined 52 patients who were scheduled for biopsy for suspected lipoma or ALT. The CEUS examination was performed using SonoVue as a contrast agent to quantify tumor perfusion using VueBox V7.1 software. Peak enhancement (PE), rise time (RT), wash-in perfusion index (WiPI), and wash-out rate (WoR) were used to assess contrast enhancement inside the STT.

Results

Among 50 tumors examined, 30 were lipomas, and 20 were ALTs. We found significant differences in perfusion between lipomas and ALTs (PE: 49.22 ± 45.75 a.u. vs. 165.67 ± 174.80; RT: 23.86 ± 20.47s vs. 10.72 ± 5.34 s; WiPI: 33.06 ± 29.94 dB vs. 107.21 ± 112.43 dB; WoR: 2.44 ± 3.70 dB/s vs. 12.75 ± 15.80 dB/s; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaImage EnhancementLipomaLiposarcomaPhospholipidsUltrasonographyAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedDiagnosis, DifferentialImage Interpretation, Computer-AssistedProspective StudiesSensitivity and SpecificitySoft Tissue NeoplasmsSulfur Hexafluoride

Substanzen

contrast agent BR1Contrast MediaPhospholipidsSulfur Hexafluoride

Autor:innen und Institutionen

  • Orthopaedics, University Hospital Heidelberg, Heidelberg, Germany.
  • Orthopaedic surgery, ARCUS Clinic Pforzheim, Pforzheim, Germany.

Zitieren

APA

Mick, P., Seeberger, A., Renkawitz, T., Lehner, B., Hariri, M., Fischer, C., & Doll, J. (2024). Contrast-enhanced ultrasound reveals perfusion differences between benign lipoma and semi-malignant atypical lipomatous tumors: A prospective clinical study. Ultraschall in der Medizin - European Journal of Ultrasound, 45(05), 509-518. https://doi.org/10.1055/a-2189-5412

Vancouver

Mick P, Seeberger A, Renkawitz T, Lehner B, Hariri M, Fischer C, et al. Contrast-enhanced ultrasound reveals perfusion differences between benign lipoma and semi-malignant atypical lipomatous tumors: A prospective clinical study. Ultraschall in der Medizin - European Journal of Ultrasound. 2024;45(05):509-518. doi:10.1055/a-2189-5412

BibTeX
@article{Mick2024,
  author = {Mick, Paul and Seeberger, Antonia and Renkawitz, Tobias and Lehner, Burkhard and Hariri, Mustafa and Fischer, Christian and Doll, Julian},
  title = {Contrast-enhanced ultrasound reveals perfusion differences between benign lipoma and semi-malignant atypical lipomatous tumors: A prospective clinical study},
  journal = {Ultraschall in der Medizin - European Journal of Ultrasound},
  year = {2024},
  volume = {45},
  number = {05},
  pages = {509--518},
  doi = {10.1055/a-2189-5412}
}
Kostenlos starten →